Phase 2Terminated
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer (AIVAA)
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer: A Double Blind, Placebo Controlled, Phase II Randomized Controlled Trial
- Sponsor
- The Canadian College of Naturopathic Medicine (Academic or other)
- Enrolment
- 3 enrolled
- Conditions
- Lung Cancer
- Interventions
- Ascorbic acid; Normal Saline
- Ages
- adults, older adults
- Registry
- NCT05849129
Full record on ClinicalTrials.gov
From the registry
This is a two arm RCT evaluating the effect of intravenous vitamin C versus placebo in patients with incurable non-small cell lung cancer. Participants in both arms will be receiving platinum doublet chemotherapy with or without concurrent immunotherapy as standard care. We plan to enroll 90 patients over 5 years.
Primary outcomes
- Change in Quality of Life
History
Last registry update
Primary completion
Started
Registered